Computational evaluation of rosemary extract (Rosmarinus officinalis) and its bioactive compounds as potential therapeutic agents for androgenic alopecia
Ife Journal of Science · 05.05.2026 · 28 (1) · 55-72
DOI: 10.4314/ijs.v28i1.5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ife Journal of Science, online erschienen am 05.05.2026. Verfasst von E. O. Ozemoya und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Androgenic alopecia (AGA), a prevalent form of hair loss, is a complex condition influenced by a combination of genetic, hormonal, and environmental factors. The search for effective and well-tolerated treatments for AGA remains an ongoing challenge. In recent years, the exploration of natural therapeutic options has gained increasing attention as an alternative to conventional pharmaceutical interventions. One such natural remedy that has garnered significant interest is rosemary extract (Rosmarinus officinalis L.). Rosemary, a herb widely used in traditional medicine, has been suggested to possess various beneficial properties, including anti-inflammatory, antioxidant, and hair growth-promoting effects. To investigate the possible therapeutic applications of rosemary extract in the management of AGA, a comprehensive computational study was conducted. This study utilized molecular docking techniques to evaluate the interactions between the identified bioactive compounds in rosemary extract and key target proteins associated with AGA, including the androgen receptor, 5α-reductase, prostaglandin D2 receptor, and transforming growth factor beta 1 (TGF-β1). The drug-likeness and pharmacokinetic properties of the phytocompounds were evaluated based on Lipinski's rule of five. The results of the computational analysis revealed promising binding affinities and interactions between the bioactive compounds in rosemary extract and the targeted proteins involved in the pathogenesis of AGA. These findings suggest that rosemary extract may possess the ability to modulate the activity of these key targets, potentially leading to the promotion of hair growth and the prevention of hair loss. The insights gained from this computational study provide a strong foundation for further investigation, including in vitro and in vivo experiments, to validate the efficacy of rosemary extract in the management of AGA. This in silico approach, combining computational methods and the exploration of natural remedies, offers a promising avenue for the development of innovative and effective treatments for this common hair disorder.
Zitieren
APA
Ozemoya, E. O., Akpan, S. E., & Eghianruwa, Q. (2026). Computational evaluation of rosemary extract (Rosmarinus officinalis) and its bioactive compounds as potential therapeutic agents for androgenic alopecia. Ife Journal of Science, 28(1), 55-72. https://doi.org/10.4314/ijs.v28i1.5
Vancouver
Ozemoya EO, Akpan SE, Eghianruwa Q. Computational evaluation of rosemary extract (Rosmarinus officinalis) and its bioactive compounds as potential therapeutic agents for androgenic alopecia. Ife Journal of Science. 2026;28(1):55-72. doi:10.4314/ijs.v28i1.5
BibTeX
@article{Ozemoya2026,
author = {Ozemoya, E. O. and Akpan, S. E. and Eghianruwa, Q.A.},
title = {Computational evaluation of rosemary extract (Rosmarinus officinalis) and its bioactive compounds as potential therapeutic agents for androgenic alopecia},
journal = {Ife Journal of Science},
year = {2026},
volume = {28},
number = {1},
pages = {55--72},
doi = {10.4314/ijs.v28i1.5}
}
EUVIMED